------------------------------------------------------------------------

Contents (.PDF) Federal Register

Contents (.TXT)                   Vol. 64, No.53

Monday, March 22, 1999

------------------------------------------------------------------------

Food and Drug Administration
RULES
ANADA 200-026, CVM98168.  Oral Dosage Form New Animal Drugs; Oxytetracycline Hydrochloride Soluble Powder.   Pages 13678-13679 [FR Doc. 99-6807] [TXT]  [PDF]
Freedom of Information Summary
NADA 141-064, CVM9897. New Animal Drugs for Use in Animal Feeds; Tilmicosin.  Page 13679 [FR Doc. 99-6669] [TXT]  [PDF]
Freedom of Information Summary
NOTICES
Docket No. 99N-0462, OC9973.  Agency Emergency Processing Request under OMB Review; Collection; Survey of Manufacturers, Distributors, Repackagers, and Other Drug Distribution Facilities for Year 2000 Compliance.  Pages 13801-13802 [FR Doc. 99-6882] [TXT]  [PDF] Written comments  by April 12, 1999

Docket No.  77N-0240, CDER9481.  Certain Single-Entity Coronary Vasodilators Containing Isosorbide Dinitrate; Opportunity for a Hearing.  Pages 13802-13804 [FR Doc. 99-6808]  [TXT]  [PDF] Hearing requests by April 21, 1999; data to support requests by May 21, 1999.

Docket No.  99N-0386, OC9979.  Talking with Stakeholders about FDA Modernization; Notice of Meetings and Teleconference.   Pages 13804-13806 [FR Doc. 99-7038]  [TXT]  [PDF]  Comments  by May 14, 1999

Questions